d.velop

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

calcifediol monohydrate, Quantity: 0.01 mg

Disponible desde:

DSM Nutritional Products Australia Pty Ltd

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: croscarmellose sodium; calcium hydrogen phosphate dihydrate; silicon dioxide; crospovidone; microcrystalline cellulose; magnesium stearate; starch sodium octenyl succinate; sodium ascorbate; dl-alpha-tocopherol; sucrose; medium chain triglycerides

Vía de administración:

Oral

indicaciones terapéuticas:

Maintain/support general health and wellbeing ; Maintain/support bone health ; Maintain/support bone strength ; Help maintain/support bone mineralisation ; Vitamin D helps calcium absorption (or words of like intent) and a diet deficient in calcium can lead to osteoporosis in later life ; Maintain/support immune system health ; Maintain/support healthy immune system function ; Maintain/support muscle function ; Maintain/support healthy neuromuscular system/function ; Maintain/support absorption of dietary (state vitamin/mineral/nutrient) ; Maintain/support (state vitamin/mineral/nutrient) levels in the body ; Helps prevent dietary (state vitamin/mineral/nutrient) deficiency

Resumen del producto:

Visual Identification: ;

Estado de Autorización:

Listed

Fecha de autorización:

2021-07-09